Visscher D W, Höyhtyä M, Ottosen S K, Liang C M, Sarkar F H, Crissman J D, Fridman R
Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201.
Int J Cancer. 1994 Nov 1;59(3):339-44. doi: 10.1002/ijc.2910590308.
The 72-kDa (MMP-2, gelatinase A) and the 92-kDa (MMP-9, gelatinase B) matrix metalloproteinases have been associated with tumor cell invasion and metastasis. Immunohistological staining of MMP-2 and MMP-9, basal lamina collagen IV and TIMP-2 were performed on frozen sections of 83 invasive breast carcinomas. MMP-2 and MMP-9 were associated with neoplastic cell plasma membrane in 72% of cases and exhibited inter-tumoral variability of staining intensity. MMP-2 and MMP-9 staining was not correlated with presence of metastases at time of diagnosis or with disease outcome. TIMP-2 was detected in the peri-tumoral stroma and was present in 87% of cases. Residual benign breast tissue was negative for TIMP-2 staining. Neoplasms with diffuse TIMP-2 staining (24%) recurred significantly more frequently (75% recurred) than cases with focal (42% recurred) or absent (27% recurred) TIMP-2. Presence of collagen IV was negatively correlated with gelatinase staining. We conclude that up-regulation of MMP-2 and MMP-9 expression in breast tumor cells is reciprocally correlated to collagen IV staining. Clinical outcome, however, is more closely related to the presence of TIMP-2 than the corresponding MMPs. Enhanced TIMP-2 expression, therefore, may denote a stromal response to tumor invasion, indicative of aggressive behavior in a subset of breast carcinomas.
72 kDa(基质金属蛋白酶-2,明胶酶A)和92 kDa(基质金属蛋白酶-9,明胶酶B)基质金属蛋白酶与肿瘤细胞侵袭和转移相关。对83例浸润性乳腺癌的冰冻切片进行了基质金属蛋白酶-2和基质金属蛋白酶-9、基底膜胶原蛋白IV和金属蛋白酶组织抑制因子-2(TIMP-2)的免疫组织化学染色。在72%的病例中,基质金属蛋白酶-2和基质金属蛋白酶-9与肿瘤细胞质膜相关,且染色强度存在肿瘤间差异。基质金属蛋白酶-2和基质金属蛋白酶-9染色与诊断时转移灶的存在或疾病转归均无相关性。TIMP-2在肿瘤周围基质中被检测到,87%的病例中存在该蛋白。残余的良性乳腺组织TIMP-2染色为阴性。TIMP-2弥漫性染色的肿瘤(24%)复发频率显著高于TIMP-2局灶性染色(42%复发)或无染色(27%复发)的病例。胶原蛋白IV的存在与明胶酶染色呈负相关。我们得出结论,乳腺肿瘤细胞中基质金属蛋白酶-2和基质金属蛋白酶-9表达的上调与胶原蛋白IV染色呈负相关。然而,临床转归与TIMP-2的存在比与相应的基质金属蛋白酶更密切相关。因此,TIMP-2表达增强可能表示基质对肿瘤侵袭的反应,提示一部分乳腺癌具有侵袭性。